The role of docetaxel in the multimodal treatment of non-small cell lung cancer

The role of docetaxel in the multimodal treatment of non-small cell lung cancer

Authors

  • Rita De Sanctis Day Hospital Oncologia A, Policlinico Umberto I, Università “Sapienza” di Roma, viale Regina Elena 324
  • Igina D’Antoni Day Hospital Oncologia A, Policlinico Umberto I, Università “Sapienza” di Roma, viale Regina Elena 324
  • Ester Del Signore Day Hospital Oncologia A, Policlinico Umberto I, Università “Sapienza” di Roma, viale Regina Elena 324
  • Bruno Gori Day Hospital Oncologia A, Policlinico Umberto I, Università “Sapienza” di Roma, viale Regina Elena 324
  • Flavia Longo Day Hospital Oncologia A, Policlinico Umberto I, Università “Sapienza” di Roma, viale Regina Elena 324

DOI:

https://doi.org/10.7175/cmi.v3i2.550

Keywords:

Non-Small Cell Lung Cancer, Brain metastases, Concurrent chemoradiotherapy, Docetaxel

Abstract

We report the case of a 53-year-old woman with brain metastatic Non-Small Cell Lung Cancer (NSCLC). Diagnosis was made during brain surgery. Brain metastases were treated both with surgery and radiotherapy. The chemotherapy schedule was cisplatin 75 mg/m2 and docetaxel 75 mg/m2 1q21 for up to six cycles. Toxicities encountered were easily manageable. Subsequent thoracic radiotherapy improved tumor response and quality of life.

Downloads

Published

2009-06-15

Issue

Section

Case report
Loading...